Celldex Therapeutics shares owned by KBC Group NV
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by KBC Group NV
from 13F filings
Historical chart of KBC Group NV investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by KBC Group NV
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $67k | 1.6k | 42.24 |